Literature DB >> 30109402

Differences in gray and white matter 18F-THK5351 uptake between behavioral-variant frontotemporal dementia and other dementias.

Hye Joo Son1, Jungsu S Oh1, Jee Hoon Roh2, Sang Won Seo3, Minyoung Oh1, Sang Ju Lee1, Seung Jun Oh1, Jae Seung Kim4.   

Abstract

PURPOSE: We investigated the regional distribution of 18F-THK5351 uptake in gray (GM) and white matter (WM) in patients with behavioral-variant frontotemporal dementia (bvFTD) and compared it with that in patients with Alzheimer's disease (AD) or semantic dementia (SD).
METHODS: 18F-THK-5351 positron emission tomography (PET), 18F-florbetaben PET, magnetic resonance imaging, and neuropsychological testing were performed in 103 subjects including 30, 24, 9, and 8 patients with mild cognitive impairment, AD, bvFTD, and SD, respectively, and 32 normal subjects. Standardized uptake value ratios (SUVRs) of 18F-THK-5351 PET images were measured from six GM and WM regions using cerebellar GM as reference. GM and WM SUVRs and WM/GM ratios, the relationship between GM SUVR and WM/GM ratio, and correlation between SUVR and cognitive function were compared.
RESULTS: In AD, both parietal GM (p < 0.001) and WM (p < 0.001) SUVRs were higher than in bvFTD. In AD and SD, the WM/GM ratio decreased as the GM SUVR increased, regardless of lobar region. In AD, memory function correlated with parietal GM (ρ = -0.74, p < 0.001) and WM (ρ = -0.53, p < 0.001) SUVR. In SD, language function correlated with temporal GM SUVR (ρ = -0.69, p = 0.006). The frontal WM SUVR was higher in bvFTD than in AD (p = 0.003) or SD (p = 0.017). The frontal WM/GM ratio was higher in bvFTD than in AD (p < 0.001). In bvFTD, the WM/GM ratio increased more prominently than the GM SUVR only in the frontal lobe (R2 = 0.026). In bvFTD, executive function correlated with frontal WM SUVR (ρ = -0.64, p = 0.014).
CONCLUSIONS: Frontal WM 18F-THK5351 uptake was higher in bvFTD than in other dementias. The increase in frontal WM uptake was greater than the increase in GM uptake and correlated with executive function. This suggests that frontal lobe WM 18F-THK5351 uptake reflects neuropathological differences between bvFTD and other dementias.

Entities:  

Keywords:  18F-THK-5351; Behavioral-variant frontotemporal dementia; PET; Tau; White matter

Mesh:

Substances:

Year:  2018        PMID: 30109402     DOI: 10.1007/s00259-018-4125-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  40 in total

1.  The spread of neurodegenerative disease.

Authors:  John Hardy; Tamas Revesz
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

2.  Head to head comparison of [18F] AV-1451 and [18F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia.

Authors:  Young Kyoung Jang; Chul Hyoung Lyoo; Seongbeom Park; Seung Jun Oh; Hanna Cho; Minyoung Oh; Young Hoon Ryu; Jae Yong Choi; Gil D Rabinovici; Hee Jin Kim; Seung Hwan Moon; Hyemin Jang; Jin San Lee; William J Jagust; Duk L Na; Jae Seung Kim; Sang Won Seo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-16       Impact factor: 9.236

3.  Typical and atypical pathology in primary progressive aphasia variants.

Authors:  Edoardo G Spinelli; Maria Luisa Mandelli; Zachary A Miller; Miguel A Santos-Santos; Stephen M Wilson; Federica Agosta; Lea T Grinberg; Eric J Huang; John Q Trojanowski; Marita Meyer; Maya L Henry; Giancarlo Comi; Gil Rabinovici; Howard J Rosen; Massimo Filippi; Bruce L Miller; William W Seeley; Maria Luisa Gorno-Tempini
Journal:  Ann Neurol       Date:  2017-03-20       Impact factor: 10.422

4.  Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

Authors:  G D Rabinovici; H J Rosen; A Alkalay; J Kornak; A J Furst; N Agarwal; E C Mormino; J P O'Neil; M Janabi; A Karydas; M E Growdon; J Y Jang; E J Huang; S J Dearmond; J Q Trojanowski; L T Grinberg; M L Gorno-Tempini; W W Seeley; B L Miller; W J Jagust
Journal:  Neurology       Date:  2011-11-30       Impact factor: 9.910

5.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Authors:  Rik Ossenkoppele; Daniel R Schonhaut; Michael Schöll; Samuel N Lockhart; Nagehan Ayakta; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Andreas Lazaris; Averill Cantwell; Jacob Vogel; Miguel Santos; Zachary A Miller; Brianne M Bettcher; Keith A Vossel; Joel H Kramer; Maria L Gorno-Tempini; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2016-03-08       Impact factor: 13.501

6.  Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia.

Authors:  Barbara Borroni; Simona Maria Brambati; Chiara Agosti; Stefano Gipponi; Giuseppe Bellelli; Roberto Gasparotti; Valentina Garibotto; Monica Di Luca; Paola Scifo; Daniela Perani; Alessandro Padovani
Journal:  Arch Neurol       Date:  2007-02

7.  Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease.

Authors:  Juan Zhou; Michael D Greicius; Efstathios D Gennatas; Matthew E Growdon; Jung Y Jang; Gil D Rabinovici; Joel H Kramer; Michael Weiner; Bruce L Miller; William W Seeley
Journal:  Brain       Date:  2010-04-21       Impact factor: 13.501

8.  Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases.

Authors:  John R Hodges; Jo Mitchell; Kate Dawson; Maria Grazia Spillantini; John H Xuereb; Paul McMonagle; Peter J Nestor; Karalyn Patterson
Journal:  Brain       Date:  2009-10-05       Impact factor: 13.501

9.  Characterization of tau positron emission tomography tracer [18F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias.

Authors:  Kerstin Sander; Tammaryn Lashley; Priya Gami; Thibault Gendron; Mark F Lythgoe; Jonathan D Rohrer; Jonathan M Schott; Tamas Revesz; Nick C Fox; Erik Årstad
Journal:  Alzheimers Dement       Date:  2016-02-15       Impact factor: 21.566

Review 10.  Glial contributions to neurodegeneration in tauopathies.

Authors:  Cheryl E G Leyns; David M Holtzman
Journal:  Mol Neurodegener       Date:  2017-06-29       Impact factor: 14.195

View more
  11 in total

1.  [18F]-AV-1451 tau PET imaging in Alzheimer's disease and suspected non-AD tauopathies using a late acquisition time window.

Authors:  Julien Lagarde; Pauline Olivieri; Fabien Caillé; Philippe Gervais; Jean-Claude Baron; Michel Bottlaender; Marie Sarazin
Journal:  J Neurol       Date:  2019-09-18       Impact factor: 4.849

Review 2.  FTD spectrum: Neuroimaging across the FTD spectrum.

Authors:  Jennifer L Whitwell
Journal:  Prog Mol Biol Transl Sci       Date:  2019-06-18       Impact factor: 3.622

Review 3.  60 Years of Achievements by KSNM in Neuroimaging Research.

Authors:  Jae Seung Kim; Hye Joo Son; Minyoung Oh; Dong Yun Lee; Hae Won Kim; Jungsu Oh
Journal:  Nucl Med Mol Imaging       Date:  2022-01-15

Review 4.  Diagnostic imaging of dementia with Lewy bodies, frontotemporal lobar degeneration, and normal pressure hydrocephalus.

Authors:  Kazunari Ishii
Journal:  Jpn J Radiol       Date:  2019-09-23       Impact factor: 2.374

Review 5.  Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.

Authors:  Konstantinos Chiotis; Alessandra Dodich; Marina Boccardi; Cristina Festari; Alexander Drzezga; Oskar Hansson; Rik Ossenkoppele; Giovanni Frisoni; Valentina Garibotto; Agneta Nordberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-15       Impact factor: 9.236

6.  18F-THK5351 PET Imaging in the Behavioral Variant of Frontotemporal Dementia.

Authors:  Gijin Nam; Hye Jin Jeong; Jae Myeong Kang; Sang-Yoon Lee; Seongho Seo; Ha-Eun Seo; Kee Hyung Park; Byeong Kil Yeon; Tatsuo Ido; Dong Jin Shin; Young Noh
Journal:  Dement Neurocogn Disord       Date:  2019-02-01

7.  Identification of Heterogeneous Subtypes of Mild Cognitive Impairment Using Cluster Analyses Based on PET Imaging of Tau and Astrogliosis.

Authors:  Hyun Jeong Lee; Eun-Chong Lee; Seongho Seo; Kwang-Pil Ko; Jae Myeong Kang; Woo-Ram Kim; Ha-Eun Seo; Sang-Yoon Lee; Yeong-Bae Lee; Kee Hyung Park; Byeong Kil Yeon; Nobuyuki Okamura; Duk L Na; Joon-Kyung Seong; Young Noh
Journal:  Front Aging Neurosci       Date:  2021-01-26       Impact factor: 5.750

8.  18F-THK5351 PET Positivity and Longitudinal Changes in Cognitive Function in β-Amyloid-Negative Amnestic Mild Cognitive Impairment.

Authors:  Min Young Chun; Jongmin Lee; Jee Hyang Jeong; Jee Hoon Roh; Seung Jun Oh; Minyoung Oh; Jungsu S Oh; Jae Seung Kim; Seung Hwan Moon; Sook-Young Woo; Young Ju Kim; Yeong Sim Choe; Hee Jin Kim; Duk L Na; Hyemin Jang; Sang Won Seo
Journal:  Yonsei Med J       Date:  2022-03       Impact factor: 2.759

Review 9.  Imaging of Reactive Astrogliosis by Positron Emission Tomography.

Authors:  Ryuichi Harada; Shozo Furumoto; Yukitsuka Kudo; Kazuhiko Yanai; Victor L Villemagne; Nobuyuki Okamura
Journal:  Front Neurosci       Date:  2022-02-08       Impact factor: 4.677

10.  18F-THK5351 PET for visualizing predominant lesions of pathologically confirmed corticobasal degeneration presenting with frontal behavioral-spatial syndrome.

Authors:  Yuji Saitoh; Etsuko Imabayashi; Masashi Mizutani; Tadashi Tsukamoto; Masato Hasegawa; Yuko Saito; Hiroshi Matsuda; Yuji Takahashi
Journal:  J Neurol       Date:  2022-04-13       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.